Trials / Not Yet Recruiting
Not Yet RecruitingNCT06376955
High Intensity Interval Versus Focused Ultrasound on Insulin Resistance in Diabetics With Abdominal Obesity
High Intensity Interval Exercise Versus Focused Ultrasound on Insulin Resistance in Diabetic Female Patients With Abdominal Obesity
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- Badr University · Academic / Other
- Sex
- Female
- Age
- 25 Years – 35 Years
- Healthy volunteers
- Not accepted
Summary
Obesity and diabetes share a common insulin resistance pathway and contribute to chronic hyperglycemia. Both high-intensity interval exercise (HIIE) and focused ultrasound (FUS) have been explored in the context of managing insulin resistance in diabetic individuals with abdominal obesity, though they operate through different mechanisms and have different implications.
Detailed description
Forty diabetic females aged 25 to 35 years old and body mass index was ≥ 30 kg/m², will participate in this study. They will be assigned into two equal groups, Group A will receive high intensity interval exercise 2 times per week for 4 months in addition to intermitted fasting diet. Group B will receive focused ultrasound 2 times per week for 4 months in addition to intermitted fasting diet. Assessment of abdominal obesity will be applied pre and post treatment through measuring Body mass index (BMI), Waist circumference (WC) in addition to Value of HbA1c and HOMA-IR hormone will be measured to determine effect of treatment on insulin resistance.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | High intensity interval exercise | HIIT is a type of interval training exercise. It incorporates several rounds that alternate between several minutes of high intensity movements followed by short periods of lower intensity movements 2 times per week for 4 months. |
| OTHER | Focused ultrasound | Focused ultrasound will be applied over the anterior abdominal, two sessions per week for 4 months, each session 40 minutes. |
Timeline
- Start date
- 2024-05-08
- Primary completion
- 2024-08-30
- Completion
- 2024-08-30
- First posted
- 2024-04-22
- Last updated
- 2024-05-08
Source: ClinicalTrials.gov record NCT06376955. Inclusion in this directory is not an endorsement.